Patents Examined by Sarae L Brausch
  • Means and methods for molecular classification of breast cancer
    Patent number: 10072301
    Abstract: The invention relates to a method of typing a sample from a breast cancer patient. More specifically, the invention relates to a method for classification of breast cancer according to the presence or absence of Estrogen Receptor (ER), Progesterone Receptor (PR) and Human Epidermal growth factor Receptor 2 (ERBB2; HER2). More specifically, the invention provides methods and means to classify breast cancer as ER positive, triple negative (ER?, PR? and HER2?) and HER2+.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: September 11, 2018
    Assignee: Agendia N.V.
    Inventors: Oscar Krijgsman, Paul Roepman, Annuska Maria Glas